Proton-linked monocarboxylate transporter (MCT)

The proton-linked monocarboxylate transporter refers to a family of membrane proteins that mediate the co-translocation of protons with monocarboxylates such as lactate, pyruvate, ketone bodies, and certain branched-chain oxo acids across biological membranes. These transporters are essential for maintaining cellular energy metabolism by facilitating rapid exchange of key metabolites between cells and tissues. There are several mammalian isoforms—most notably MCT1, which is widely expressed but especially abundant in heart and red muscle; MCT2, found where high-affinity uptake is needed; MCT3, restricted mainly to retinal pigment epithelium; and MCT4, prominent in white muscle fibers with high glycolytic rates including many tumors. The activity of these transporters underpins critical processes like the Warburg effect seen in cancer cells. Pharmacological inhibition—particularly targeting tumor-expressed subtypes like MCT1/MCT4—is being explored as an anticancer strategy because it can disrupt both energy production within cancer cells and their interaction with the microenvironment. Some inhibitors are already undergoing clinical evaluation. However, given their physiological importance throughout the body—including roles in cardiac function, neuronal activity, renal handling—the safety profile requires careful consideration.

Other names

Monocarboxylate transporterProton-coupled monocarboxylate transporterSLC16A family (gene family designation)MCT1 (SLC16A1)MCT2 (SLC16A7)MCT3 (SLC16A8)MCT4 (SLC16A3)

Inhibition blocks lactate/pyruvate transport across cell membranes, disrupting tumor metabolism and acid-base balance. - For cancer therapy: impairs metabolic symbiosis between tumor/stromal cells by blocking lactate export/import. - For other conditions: modulates tissue pH or substrate availability.